The frequency and management of asparaginase-related thrombosis in paediatric and adult patients with acute lymphoblastic leukaemia treated on Dana-Farber Cancer Institute consortium protocols

British Journal of Haematology

Volumn 152, Issue 4, 2011, Pages 452-459

  Grace, Rachael F ^a,b   Dahlberg, Suzanne E ^b,c   Neuberg, Donna ^b,c   Sallan, Stephen E ^a,b   Connors, Jean M ^b,c   Neufeld, Ellis J ^a,b   DeAngelo, Daniel J ^b,c   Silverman, Lewis B ^a,b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

Acute lymphoblastic leukaemia; Anticoagulation; Asparaginase; Management; Thrombosis

Indexed keywords

ASPARAGINASE; ASPARAGINASE MACROGOL; LOW MOLECULAR WEIGHT HEPARIN; UROKINASE; WARFARIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGE; ARTICLE; BRAIN HEMORRHAGE; CEREBRAL SINUS THROMBOSIS; CHILD; CLINICAL ARTICLE; COMPARTMENT SYNDROME; CONTROLLED STUDY; DRUG WITHDRAWAL; EVENT FREE SURVIVAL; FEMALE; HIGH RISK PATIENT; HUMAN; INFANT; INTRACARDIAC THROMBOSIS; LEG THROMBOSIS; LUNG EMBOLISM; MALE; PREDICTION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; SCHOOL CHILD; TREATMENT OUTCOME; UNITED STATES; VENOUS THROMBOEMBOLISM;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGE FACTORS; ANTICOAGULANTS; ANTINEOPLASTIC AGENTS; ASPARAGINASE; CHILD; CHILD, PRESCHOOL; CLINICAL PROTOCOLS; DRUG ADMINISTRATION SCHEDULE; EPIDEMIOLOGIC METHODS; HUMANS; INFANT; INFANT, NEWBORN; MIDDLE AGED; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROGNOSIS; RECURRENCE; TREATMENT OUTCOME; VENOUS THROMBOEMBOLISM; YOUNG ADULT;

EID: 78851470328     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2010.08524.x     Document Type: Article

References (36)

1. Andrew, M., Brooker, L. & Mitchell, L. (1994) Acquired antithrombin III deficiency secondary to asparaginase therapy in childhood acute lymphoblastic leukaemia. Blood Coagulation and Fibrinolysis, 5(Suppl 1), S24-S36; discussion S59-64.
2. Appel, I.M., Hop, W.C., van Kessel-Bakvis, C., Stigter, R. & Pieters, R. (2008) L-Asparaginase and the effect of age on coagulation and fibrinolysis in childhood acute lymphoblastic leukemia. Thrombosis and Haemostasis, 100, 330-337.
3. Athale, U.H., Siciliano, S.A., Crowther, M., Barr, R.D. & Chan, A.K. (2005) Thromboembolism in children with acute lymphoblastic leukaemia treated on Dana-Farber Cancer Institute protocols: effect of age and risk stratification of disease. British Journal of Haematology, 129, 803-810.
4. Barry, E., DeAngelo, D.J., Neuberg, D., Stevenson, K., Loh, M.L., Asselin, B.L., Barr, R.D., Clavell, L.A., Hurwitz, C.A., Moghrabi, A., Samson, Y., Schorin, M., Cohen, H.J., Sallan, S.E. & Silverman, L.B. (2007) Favorable outcome for adolescents with acute lymphoblastic leukemia treated on Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium Protocols. Journal of Clinical Oncology, 25, 813-819.
5. Carlsson, H., Stockelberg, D., Tengborn, L., Braide, I., Carneskog, J. & Kutti, J. (1995) Effects of Erwinia-asparaginase on the coagulation system. European Journal of Haematology, 55, 289-293.
6. Caruso, V., Iacoviello, L., Di Castelnuovo, A., Storti, S., Mariani, G., de Gaetano, G. & Donati, M.B. (2006) Thrombotic complications in childhood acute lymphoblastic leukemia: a meta-analysis of 17 prospective studies comprising 1752 pediatric patients. Blood, 108, 2216-2222.
7. Caruso, V., Iacoviello, L., Di Castelnuovo, A., Storti, S. & Donati, M.B. (2007) Venous thrombotic complications in adults undergoing induction treatment for acute lymphoblastic leukemia: results from a meta-analysis. Journal of Thrombosis and Haemostasis, 5, 621-623.
8. DeAngelo, D.J., Dahlberg, S.E., Silverman, L., Couban, S., Amrein, P.C. & Setfel, M.D. (2007) A multicenter phase II study using a dose intensified pediatric regimen in adults with untreated acute lymphoblastic leukemia. Blood (ASH Annual Meeting Abstracts), 110, 587.
9. Duval, M., Suciu, S., Ferster, A., Rialland, X., Nelken, B., Lutz, P., Benoit, Y., Robert, A., Manel, A.M., Vilmer, E. et al (2002) Comparison of Escherichia coli-asparaginase with Erwinia-asparaginase in the treatment of childhood lymphoid malignancies: results of a randomized European Organisation for Research and Treatment of Cancer-Children's Leukemia Group phase 3 trial. Blood, 99, 2734-2739.
10. Elliott, M.A., Wolf, R.C., Hook, C.C., Pruthi, R.K., Heit, J.A., Letendre, L.L., Tefferi, A., Kaufmann, S.H., Mesa, R.A. & Litzow, M.R. (2004) Thromboembolism in adults with acute lymphoblastic leukemia during induction with L-asparaginase-containing multi-agent regimens: incidence, risk factors, and possible role of antithrombin. Leukaemia & Lymphoma, 45, 1545-1549.
11. Gugliotta, L., Mazzucconi, M.G., Leone, G., Mattioli-Belmonte, M., Defazio, D., Annino, L., Tura, S. & Mandelli, F. (1992) Incidence of thrombotic complications in adult patients with acute lymphoblastic leukaemia receiving L-asparaginase during induction therapy: a retrospective study. The GIMEMA Group. European Journal of Haematology, 49, 63-66.
12. Hunault-Berger, M., Chevallier, P., Delain, M., Bulabois, C.E., Bologna, S., Bernard, M., Lafon, I., Cornillon, J., Maakaroun, A., Tizon, A. et al (2008) Changes in antithrombin and fibrinogen levels during induction chemotherapy with L-asparaginase in adult patients with acute lymphoblastic leukemia or lymphoblastic lymphoma. Use of supportive coagulation therapy and clinical outcome: the CAPELAL study. Haematologica, 93, 1488-1494.
13. Ku, G.H., White, R.H., Chew, H.K., Harvey, D.J., Zhou, H. & Wun, T. (2009) Venous thromboembolism in patients with acute leukemia: incidence, risk factors, and effect on survival. Blood, 113, 3911-3917.
14. Kuhle, S., Lau, A., Bajzar, L., Vegh, P., Halton, J., Cherrick, I., Anderson, R., Desai, S., McCusker, P., Wu, J. et al (2006) Comparison of the anticoagulant effect of a direct thrombin inhibitor and a low molecular weight heparin in an acquired antithrombin deficiency in children with acute lymphoblastic leukaemia treated with L-asparaginase: an in vitro study. British Journal of Haematology, 134, 526-531.
15. Meister, B., Kropshofer, G., Klein-Franke, A., Strasak, A.M., Hager, J. & Streif, W. (2008) Comparison of low-molecular-weight heparin and antithrombin versus antithrombin alone for the prevention of symptomatic venous thromboembolism in children with acute lymphoblastic leukemia. Pediatric Blood & Cancer, 50, 298-303.
16. Mitchell, L., Hoogendoorn, H., Giles, A.R., Vegh, P. & Andrew, M. (1994a) Increased endogenous thrombin generation in children with acute lymphoblastic leukemia: risk of thrombotic complications in L'Asparaginase-induced antithrombin III deficiency. Blood, 83, 386-391.
17. Mitchell, L.G., Halton, J.M., Vegh, P.A., Barr, R.D., Venneri, T., Pai, K.M. & Andrew, M.E. (1994b) Effect of disease and chemotherapy on hemostasis in children with acute lymphoid leukemia. The American Journal of Pediatric Hematology/Oncology, 16, 120-126.
18. Mitchell, L.G., Sutor, A.H. & Andrew, M. (1995) Hemostasis in childhood acute lymphoblastic leukemia: coagulopathy induced by disease and treatment. Seminars in Thrombosis and Hemostasis, 21, 390-401.
19. Mitchell, L.G., Andrew, M., Hanna, K., Abshire, T., Halton, J., Anderson, R., Cherrick, I., Desai, S., Mahoney, D., McCuster, P. et al (2003) A prospective cohort study determining the prevalence of thrombotic events in children with acute lymphoblastic leukemia and a central venous line who are treated with L-asparaginase: results of the Prophylactic Antithrombin Replacement in Kids with Acute Lymphoblastic Leukemia Treated with Asparaginase (PARKAA) Study. Cancer, 97, 508-516.
20. Moghrabi, A., Levy, D.E., Asselin, B., Barr, R., Clavell, L., Hurwitz, C., Samson, Y., Schorin, M., Dalton, V.K., Lipshultz, S.E. et al (2007) Results of the Dana-Farber Cancer Institute ALL Consortium Protocol 95-01 for children with acute lymphoblastic leukemia. Blood, 109, 896-904.
21. Mohren, M., Markmann, I., Jentsch-Ullrich, K., Koenigsmann, M., Lutze, G. & Franke, A. (2006) Increased risk of venous thromboembolism in patients with acute leukaemia. British Journal of Cancer, 94, 200-202.
22. Monagle, P., Barnes, C., Igniatovic, V., Furmedge, J., Newell, F., Chan, A., DeRosa, L., Hamilton, S., Ragg, P., Robinson, S., Auldist, A., Crock, C., Roy, N. & Rowlands, S. (2006) Developmental haemostasis. Impact for clinical haemostasis laboratories. Thrombosis and Haemostasis, 95, 362-372.
23. Monagle, P., Chalmers, E., Chan, A., DeVeber, G., Kirkham, F., Massicotte, P. & Michelson, A.D. (2008) Antithrombotic therapy in neonates and children: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest, 133(6 Suppl), 887S-968S.
24. Nowak-Gottl, U., Ahlke, E., Schulze-Westhoff, P. & Boos, J. (1996a) Changes in coagulation and fibrinolysis in childhood ALL: a two-step dose reduction of one E. coli asparaginase preparation. British Journal of Haematology, 95, 123-126.
25. Nowak-Gottl, U., Werber, G., Ziemann, D., Ahlke, E. & Boos, J. (1996b) Influence of two different Escherichia coli asparaginase preparations on fibrinolytic proteins in childhood ALL. Haematologica, 81(2), 127-131.
26. Nowak-Gottl, U., Heinecke, A., von Kries, R., Nurnberger, W., Munchow, N. & Junker, R. (2001) Thrombotic events revisited in children with acute lymphoblastic leukemia: impact of concomitant Escherichia coli asparaginase/prednisone administration. Thrombosis Research, 103, 165-172.
27. Nowak-Gottl, U., Kenet, G. & Mitchell, LG. (2009) Thrombosis in childhood acute lymphoblastic leukaemia: epidemiology, aetiology, diagnosis, prevention and treatment. Best Practice & Research. Clinical Haematology, 22, 103-114.
28. Payne, J.H. & Vora, A.J. (2007) Thrombosis and acute lymphoblastic leukaemia. British Journal of Haematology, 138, 430-445.
29. Priest, J.R., Ramsay, N.K., Steinherz, P.G., Tubergen, D.G., Cairo, M.S., Sitarz, A.L., Bishop, A.J., White, L., Trigg, M.E., Levitt, C.J. et al (1982) A syndrome of thrombosis and hemorrhage complicating L-asparaginase therapy for childhood acute lymphoblastic leukemia. Journal of Pediatrics, 100, 984-989.
30. Qureshi, A., Mitchell, C., Richards, S., Vora, A. & Goulden, N. (2010) Asparaginase-related venous thrombosis in UKALL 2003- re-exposure to asparaginase is feasible and safe. British Journal of Haematology, 149, 410-413.
31. Rodgers, G.M. (2009) Role of antithrombin concentrate in treatment of hereditary antithrombin deficiency. An update. Thrombosis and Haemostasis, 101, 806-812.
32. Silverman, L.B., Gelber, R.D., Dalton, V.K., Asselin, B.L., Barr, R.D., Clavell, L.A., Hurwitz, C.A., Moghrabi, A., Samson, Y., Schorin, M.A. et al (2001) Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01. Blood, 97, 1211-1218.
33. Silverman, L.B., Stevenson, K.E., O'Brien, J.E., Asselin, B.L., Barr, R.D., Clavell, L., Cole, P.D., Kelly, K.M., Laverdiere, C., Michon, B. et al (2010a) Long-term results of Dana-Farber Cancer Institute ALL Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1985-2000). Leukemia, 24, 320-334.
34. Silverman, L.B., Supko, J.G., Stevenson, K.E., Woodward, C., Vrooman, L.M., Neuberg, D.S., Asselin, B.L., Athale, U.H., Clavell, L., Cole, P.D. et al (2010b) Intravenous PEG-asparaginase during remission induction in children and adolescents with newly diagnosed acute lymphoblastic leukemia. Blood, 115, 1351-1353.
35. Sutor, A.H., Mall, V. & Thomas, K.B. (1999) Bleeding and thrombosis in children with acute lymphoblastic leukaemia, treated according to the ALL-BFM-90 protocol. Klinische Padiatrie, 211, 201-204.
36. Vrooman, L.M., Supko, J.G., Neuberg, D.S., Asselin, B.L., Athale, U.H., Clavell, L., Kelly, K.M., Laverdiere, C., Michon, B., Schorin, M. et al (2010) Erwinia asparaginase after allergy to E. coli asparaginase in children with acute lymphoblastic leukemia. Pediatric Blood & Cancer, 54, 199-205.